VWF and blood coagulation disease: Taken together, these changes explain the characteristic laboratory profile of COVID-19-associated coagulopathy: elevated D-dimer, moderately prolonged PT, initially raised fibrinogen that may later fall, the presence of FDP, mild thrombocytopenia and reduced antithrombin, together with increased factor VIII and vWF levels (Table 3).